Episodic migraine is the most common form of migraine, defined by having fewer than 15 headache days per month. It affects roughly 1 in 4 adults worldwide, making it the leading cause of disability in people under 50. Unlike a regular headache, an episodic migraine is a neurological event that unfolds in distinct phases and can disrupt hours or even days of your life.
How Episodic Migraine Is Defined
The dividing line between episodic and chronic migraine is 15 headache days per month. If you experience headaches on fewer than 15 days per month, your migraine is classified as episodic. Once headaches hit 15 or more days per month for at least three months, with migraine features on at least 8 of those days, the diagnosis shifts to chronic migraine.
Within the episodic category, doctors often break things down further by frequency. Low-frequency episodic migraine means 4 or fewer headache days per month. Medium-frequency is 5 to 9 days, and high-frequency is 10 to 14 days. These distinctions matter because your frequency level shapes how much the condition affects your daily life and which treatments make sense. Among people with low-frequency episodic migraine, about 14.5% experience severe disability. That number jumps to nearly 50% for those in the high-frequency range.
The Four Phases of an Attack
A migraine attack is not just a headache. It can move through up to four distinct phases, though not everyone experiences all of them.
The prodrome starts hours or even days before the pain arrives. You might notice neck stiffness, unusual fatigue, sensitivity to light or sound, food cravings, or mood changes. Learning to recognize your prodrome can give you a valuable head start on treatment.
The aura phase affects roughly one-third of people with migraine. It typically lasts 5 to 60 minutes and involves visual disturbances like zigzag lines, blind spots, or flashing lights. Some people experience tingling in the face or hands, or temporary difficulty finding words. Aura almost always resolves on its own before or as the headache begins.
The headache phase is the most recognizable part of an attack. Pain is usually moderate to severe, often on one side of the head, and has a throbbing or pulsating quality. Nausea, vomiting, and extreme sensitivity to light, sound, and smells are common. This phase can last anywhere from 4 to 72 hours if untreated.
The postdrome, sometimes called a “migraine hangover,” lingers for up to 48 hours after the pain ends. Difficulty concentrating, fatigue, and neck stiffness are the most frequently reported symptoms. Many people describe feeling washed out or mentally foggy during this window.
What Happens in Your Brain During a Migraine
Migraine was once thought to be a blood vessel problem. The current understanding is that it starts in the brain itself. Something, whether it’s a change in hypothalamic activity, a surge in cortical excitability, or an external trigger, activates a network of pain-sensing nerves called the trigeminovascular system. These nerve fibers densely line the membranes surrounding the brain and its blood vessels.
Once activated, certain nerve fibers release a signaling molecule called CGRP. This molecule sets off a cascade: blood vessels dilate, surrounding tissue becomes inflamed, and neighboring nerve fibers that carry pain signals become sensitized. That sensitization is why, once a migraine is underway, even normal stimuli like light or gentle touch can feel unbearable. CGRP also acts within a nerve cluster called the trigeminal ganglion, where it interacts with surrounding cells to amplify and sustain the pain signal. This understanding of CGRP’s role has driven the development of newer migraine treatments that specifically block its activity.
Common Triggers
Most people with episodic migraine can identify at least one trigger, though attacks are often set off by a combination of factors rather than a single cause. In a large study of over 1,000 people with migraine, the most frequently reported triggers were:
- Stress: reported by nearly 80% of participants, making it the single most common trigger across all groups
- Hormonal changes: reported by 65%, with menstruation being the top trigger for women specifically
- Skipping meals or fasting: 57%
- Weather changes: 53%
- Sleep disturbances: 50%, including both too little sleep and oversleeping
- Strong smells: 44%, with perfume being the most common offender. In a study of odor-triggered attacks, 70% of people reported the migraine beginning within 30 minutes of exposure
- Alcohol: 38%, with red wine more commonly cited than other drinks
- Bright or glaring light: 38%
Triggers tend to differ somewhat between men and women. Sleep deprivation, stress, and bright lights are the three most common triggers in men, while menstruation, stress, and bright lights top the list for women. Notably, triggers become more common as people age and as the duration of their migraine disease increases.
The Risk of Progression to Chronic Migraine
Episodic migraine can transform into chronic migraine over time, and several modifiable risk factors influence that progression. The most significant is overuse of acute pain medication. A meta-analysis found that medication overuse was associated with an 8.8-fold increased risk of progressing to chronic migraine. “Overuse” generally means taking pain relievers on 10 to 15 or more days per month, depending on the type of medication.
Poor sleep is another major driver. People with chronic migraine are more likely to have insomnia, sleep apnea, and poor overall sleep quality compared to those with episodic migraine. A population-based study found that people with chronic daily headache were nearly three times more likely to snore than those with episodic headache, even after accounting for other factors, with evidence of a dose-response relationship.
Other risk factors supported by good evidence include extra-cephalic chronic pain conditions (like back pain or fibromyalgia), psychiatric symptoms such as depression and anxiety, physical inactivity, high caffeine intake, obesity and other metabolic conditions, tobacco use, and financial constraints that limit access to care. Many of these factors are modifiable, which means addressing them can help keep episodic migraine from worsening.
How Episodic Migraine Is Treated
Treatment falls into two categories: stopping an attack that’s already started and preventing future attacks.
Acute Treatment
For mild to moderate attacks, over-the-counter pain relievers are often the first step. For more severe attacks, a class of prescription medications called triptans has been the standard for decades. Triptans work by narrowing blood vessels and blocking pain pathways in the trigeminal system. They’re most effective when taken early in an attack.
Newer options called gepants take a different approach by blocking CGRP, the signaling molecule that drives migraine pain. Unlike triptans, gepants don’t constrict blood vessels, which makes them an option for people with certain cardiovascular conditions. Some gepants can be used for both stopping individual attacks and preventing them.
Regardless of which acute treatment you use, the key caution is frequency. Using any acute medication too often, typically more than 2 to 3 days per week, raises the risk of medication-overuse headache and progression to chronic migraine.
Preventive Treatment
Preventive therapy is generally considered when you’re experiencing 4 or more migraine days per month, when attacks are severe and disabling, or when acute treatments aren’t working well enough. The goal is to reduce how often attacks happen and how severe they are.
Several classes of daily oral medications are used for prevention, including certain blood pressure medications, antidepressants, and anti-seizure drugs. These weren’t originally designed for migraine but have proven effective at reducing attack frequency. For people who don’t respond to or can’t tolerate these options, newer injectable treatments that target CGRP or its receptor are given monthly or quarterly and have shown strong results in clinical trials.
Non-drug approaches also play a meaningful role. Given that stress is the most commonly reported trigger, behavioral strategies like cognitive behavioral therapy and relaxation techniques can reduce attack frequency. Regular sleep habits, consistent meal timing, regular aerobic exercise, and identifying your personal triggers form the foundation of migraine management, regardless of what medications you use.
The Broader Impact
Migraine is the second most common cause of disability worldwide and the leading cause of years lived with disability among adults aged 15 to 49. In the United States alone, people with migraine report approximately 112 million bedridden days per year, encompassing both missed work and days where productivity is significantly impaired.
Even within the episodic range, the impact on daily life scales sharply with frequency. Self-reported disability rates nearly double as headache frequency increases: 4.4% of people with low-frequency episodic migraine report being on short- or long-term disability, compared to 6.4% for medium-frequency and 7.9% for high-frequency episodic migraine. The gap between measured disability and self-reported disability suggests that many people with episodic migraine are pushing through significant impairment without recognizing it as a formal disability, or without access to accommodations that could help.